Featured Articles

  1. Formulation: The Key To Long‑Term Success 1/21/2026

    Robust formulations protect long‑term biologic stability, safety, and efficacy by combining scientific insight, early modeling, and process‑aware development to handle variability.

  2. From Syringes To Wearables: Formulation's Impact 1/21/2026

    High‑concentration biologic formulations for prefilled syringes and on‑body devices enable easier self‑administration, reduce treatment burden, boost adherence, and address complex formulation challenges.

  3. A CRDO Path To Faster Biologic Development 1/21/2026

    A science‑driven CRDO model accelerates biologic development by combining expert formulation, analytics, and partnerships to reduce risk and improve outcomes.

  4. Mass Spectrometry From Discovery To Launch 1/21/2026

    Mass spectrometry is now a fast, sensitive tool that supports drug discovery, development, quality control, and lifecycle management through detailed molecular analysis.

  5. Driving Biologics Formulation Through Digital, In Silico Transformation 1/21/2026

    AI, ML, NLP, and other in‑silico tools are transforming biologics formulation by enabling earlier risk assessment, better formulatability predictions, and faster preclinical workflows.

  6. Advancing Subvisible Particle Characterization With AI 1/14/2026

    An advanced approach leveraging artificial intelligence identifies the root causes of aggregation, streamlining formulation development and ensuring consistent product quality across every batch.

  7. Formulation Development Experience For Effective Particle Identification 1/14/2026

    Combining advanced analytics with deep formulation knowledge enables precise root-cause analysis, preventing manufacturing delays and ensuring that products remain high-quality and safe for patients.